Skip to search formSkip to main contentSkip to account menu

fedotozine

Known as: 1-phenyl-1-((3,4,5-trimethoxy)benzoyloxymethyl)-N,N-dimethyl-n-propylamine, Benzenemethanamine, alpha-ethyl-N,N-dimethyl-alpha-(((3,4,5-trimethoxyphenyl)methoxy)methyl)-, (R)- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Diabetic gastroparesis is a common and debilitating condition affecting millions of patients with diabetes mellitus worldwide… 
Highly Cited
1999
Highly Cited
1999
BACKGROUND & AIMS Visceral hypersensitivity plays a major role in the pathophysiology of inflammatory bowel syndrome (IBS… 
Highly Cited
1997
Highly Cited
1997
Background—Peripheral kappa receptor agonists may provide a new therapeutic approach for the treatment of functional dyspepsia… 
Highly Cited
1996
Highly Cited
1996
Background and Aim: Gastric hypersensitivity to mechanical distension has been observed in functional dyspepsia, but no drug is… 
Highly Cited
1995
Highly Cited
1995
The efficacy and safety of the peripheral kappa agonist fedotozine was evaluated in a double-blind, multicenter study involving… 
1994
1994
The efficacy and safety of the peripheral kappa-receptor agonist fedotozine was investigated in a double-blind, placebo… 
1994
1994
BACKGROUND/AIMS Gastric motor disturbances, associated with a delay in gastric emptying, occur in patients with the irritable… 
1994
1994
Two kappa agonists, fedotozine and trans-(+/-)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolydinyl)-cyclohexyl ]- benzeneacetamide… 
1990
1990
Abstract— The effects of fedotozine, (+)‐(1R)‐1‐phenyl‐1‐[(3,4,5‐trimethoxy)benzyloxymethyl]‐N,N‐ dimethyl‐n‐propylamine, on…